You can buy or sell CORV and other stocks, options, ETFs, and crypto commission-free!
Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. Read More The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients, and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada.
Vancouver, British Columbia
52 Week High
52 Week Low
Yahoo FinanceMay 1
Correvio to Report First Quarter 2019 Financial Results on May 8, 2019
Conference Call Scheduled for Wednesday, May 8, 2019 at 8:30 a.m. Eastern (5:30 a.m. Pacific) NASDAQ: CORV TSX: CORV VANCOUVER , May 1, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, announces that it will report financial results for the first quarter ended March 31, 2019 on Wednesday, May 8, 2019 . Correvio will hold a conference call and webcast at 8:30 a.m. Eastern (5:30 a.m. Pacific) on that day to discuss ...
Expected Aug 7, Pre-Market